Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

Idis

- PMLiVE

Clinigen launches ‘What is Possible?’ campaign on Rare Disease Day to accelerate access to medicines

There are over 7,000 rare diseases impacting more than 300 million people globally

- PMLiVE

Clinigen’s NaviGATE programme reveals knowledge gaps in rare disease community

There are over 7,000 rare diseases that impact more than 300 million people globally

- PMLiVE

Clinigen launches educational programme for rare disease patients and organisations

The NaviGATE programme will aim to empower patients and provide navigational support

- PMLiVE

Quantum Pharma confirms Clinigen takeover bid

Clinigen has until September 13 to make a formal offer

- PMLiVE

Managed Access Programmes: a powerful source of real-world insight

MAPs represent a unique opportunity to gather evidence from a cohort of patients receiving the same treatment, across multiple countries prospectively before launch

Allergan logo

Allergan stumps up $375m for bolt-on acquisitions

Firm has recently added two migraine drugs and Oculeve to its portfolio

- PMLiVE

Perrigo buys consumer health products from GSK

Several over-the-counter drug assets acquired at an undisclosed price

- PMLiVE

J&J signs $1bn deal with Achillion for hepatitis C therapies

Will license three candidates from Achillion Pharma

- PMLiVE

Juno boosts CAR-T presence with $80m German acquisition

Stage Cell Therapeutics will contribute in process development and manufacturing

Celgene building

Celgene to acquire biotech firm Quanticel Pharmaceuticals

Firm hopes to expand its pipeline of life-enhancing products for cancer patients

- PMLiVE

Clinigen acquires Idis for £225m

Acquisition makes them the global leader in unlicensed medicines

- PMLiVE

Piramal sells clinical research arm to Indoco

Piramal Clinical Research sold for an undisclosed sum

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links